Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 23 days ago
Share
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
546 patients around the world
Available in
Puerto Rico, Argentina, United States
Gilead Sciences
1
Research sites
546
Patients around the world
This study is for people with
Hiv
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Helios Salud S.A. Dr. Stamboulian - Sede Central - CABA
Recruiting
View site
Perú 1515, CABA, Buenos Aires
Helios Salud S.A. Dr. Stamboulian - Sede Central - CABA
Recruiting
View site
Perú 1515, CABA, Buenos Aires
See details
Contact us
Contact us
Study
ARTISTRY-2
Sponsor
Gilead Sciences
Conditions
Hiv
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06333808
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent